Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro supplies in the UK take a specific, fixed form: one pre-filled KwikPen containing four weekly doses of tirzepatide, dispensed only on a valid prescription following a clinical assessment. Each pen covers a single month of treatment at your current dose. That's the factual answer, and it matters — because a surprisingly large number of people searching for Mounjaro supplies have been misled about what legitimate supply looks like. As a prescription-only medicine, Mounjaro can only be lawfully obtained through a regulated UK pharmacy after a prescriber has assessed your suitability. The pen format, the dose, the storage requirements and the dispensing route are fixed by licence, not chosen by the seller.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Search for Mounjaro supplies online and you will quickly find sellers offering multi-dose vials, powder for reconstitution, or loose pen components described as "genuine tirzepatide". None of that is licensed Mounjaro. The only authorised UK presentation is the KwikPen, a disposable, pre-filled auto-injector made by Eli Lilly, sealed at manufacture, with a fixed dose built in. There is no vial format, no cartridge, no powder version licensed for human use in the UK. If a seller is offering anything other than a sealed Eli Lilly KwikPen, dispensed by a GPhC-registered pharmacy on a valid UK prescription, what they are selling is not legitimate Mounjaro.
The MHRA has issued repeated warnings about counterfeit and unlicensed injectable medicines circulating online, including fake pens that have been found to contain incorrect or dangerous substances. If you want to understand what the regulator has found and seized, the MHRA's Yellow Card portal is the right place to start, you can also use it to report anything that concerns you. Counterfeit supply is not a fringe risk. It is documented and ongoing.
The safest verification step is straightforward: check that the pharmacy dispensing your treatment holds a current GPhC registration. You can do that at the GPhC pharmacy register. A legitimate dispensing pharmacy will have a live registration number, and at nume, ours is 9012878, publicly searchable on that register.
When tirzepatide is dispensed legitimately through a regulated UK pharmacy, the KwikPen arrives cold, refrigerated in transit to maintain the 2–8°C storage requirement. At nume, the pen comes in plain, unbranded packaging via DPD, with a tracking link sent to your phone so you know exactly when to expect it. Inside: the sealed Eli Lilly KwikPen at your prescribed dose, the patient information leaflet, and any clinical correspondence from your prescriber. There is no loose needle, no vial, no instruction to mix anything.
The pen itself is designed for subcutaneous injection into the abdomen, thigh or upper arm, with sites rotated weekly. Injection technique, site rotation and storage details are covered in the patient information leaflet that comes with every pen, for the exact storage window at room temperature, always defer to that leaflet, as the figures are dose-specific and change with reformulations.
If you are trying to understand how supplies are priced and what a monthly cost actually includes, the Mounjaro price comparison guide sets that out clearly. And if you are weighing up how the treatment plan typically progresses over time, the weight loss curve page explains what the clinical trial data shows at each stage of treatment.
Mounjaro is licensed for adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as high blood pressure, raised cholesterol, prediabetes, type 2 diabetes or obstructive sleep apnoea. For some ethnic backgrounds (including South Asian, Chinese, Middle Eastern, Black African and African-Caribbean) UK guidance applies thresholds that are 2.5 kg/m² lower. The NHS tirzepatide guidance sets out the full eligibility picture alongside the standard side-effect information every patient should read before starting.
A BMI figure alone does not guarantee a prescription. A GPhC-registered prescriber reviews the whole clinical picture: current medications, relevant history, contraindications and whether the benefits outweigh the risks for that individual. Mounjaro is not licensed for people under 18, and it is not recommended during pregnancy, when breastfeeding, or when actively trying to conceive. Those considering it for weight management while using oral contraceptives should know that prescribers will typically advise adding a non-oral method for the first four weeks of treatment and for four weeks after each dose increase, because tirzepatide may reduce pill absorption.
If you are exploring whether a private route might suit you, the tirzepatide overview covers the clinical background, and details of how the supply chain works for private patients are on the Mounjaro suppliers page. For those specifically looking at how to change their current supply arrangement, the guidance on changing Mounjaro supplier is worth reading before making any decisions.
Legitimate Mounjaro supplies in the UK reach patients through one route: a GPhC-registered pharmacy dispenses against a valid UK prescription issued by a qualified prescriber. Social media sellers, bulk-purchase listings and "no consultation needed" offers sit outside that route entirely. Price is not a reliable guide, counterfeit supply is sometimes priced comparably to genuine product precisely to appear credible. The relevant red flags are: no requirement for a prescription, no visible GPhC registration, no clinical review, and supply arriving without cold-chain packaging.
If you want to understand the broader landscape of UK-regulated Mounjaro suppliers, the guide to choosing a UK supplier covers what to check. For people searching locally, the suppliers near me page explains how regulated online pharmacies fit into that picture. And for broader context on the tirzepatide supply chain, the tirzepatide supplier overview is a useful reference.
A question our prescribers hear regularly: can you split a pen between two people to share the cost? No. Each KwikPen is prescribed to a named patient at a specific dose, and sharing a prescription medicine is unlawful. The dose matters clinically too, someone at 5 mg and someone at 10 mg are not interchangeable. If cost is a genuine concern, the honest answer is that it is worth reading what a legitimate monthly supply actually includes before comparing headline prices. Starting a free consultation at our treatment page is the first step to getting a clear picture of whether you are eligible and what supply would look like for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.